Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma
Status:
Active, not recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to evaluate an investigational vaccine using
patent-derived dendritic cells (DC) to treat malignant glioma or glioblastoma.